4.7 Article

Recombinant Vascular Endothelial Growth Factor 121 Infusion Lowers Blood Pressure and Improves Renal Function in Rats With Placental Ischemia-Induced Hypertension

期刊

HYPERTENSION
卷 55, 期 2, 页码 380-385

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/HYPERTENSIONAHA.109.141937

关键词

preeclampsia; gestation; VEGF; blood pressure; angiogenic

资金

  1. National Institutes of Health [HL38499, HL51971, HL90269]

向作者/读者索取更多资源

Antagonism of vascular endothelial growth factor (VEGF) signaling by soluble fms-like tyrosine kinase 1 occurs during preeclampsia and is proposed to play an important role in the pathogenesis of preeclampsia. We reported recently that hypertension associated with chronic reductions in uteroplacental perfusion pressure (RUPP) is associated with increased soluble fms-like tyrosine kinase 1 and decreased free VEGF. Whether restoration of circulating VEGF can restore renal function and chronically decrease arterial pressure associated with placental ischemia remains unknown. We hypothesized that chronic infusion of VEGF(121) would attenuate hypertension, increase glomerular filtration rate, and reverse the endothelial dysfunction associated with chronic RUPP. VEGF(121) (at either 90 or 180 mu g/kg per day) was administered for 5 days via osmotic minipump placed IP. Mean arterial pressure, renal function, and tissues were obtained on day 19 of pregnancy from RUPP+VEGF, RUPP, and normal pregnant dams. Mean arterial pressure was increased in the RUPP (131 +/- 3 mm Hg) compared with the normal pregnant (102 +/- 1 mm Hg) rats, and infusion of VEGF(121) resolved the hypertension (105 +/- 5 mm Hg). Glomerular filtration rate was decreased in the RUPP dams (1.5 +/- 0.3 mL/min) and restored to normal pregnant levels (3.1 +/- 0.5 mL/min) by VEGF(121) treatment (3.1 +/- 0.4 mL/min). Effective renal plasma flow, decreased by RUPP, was also increased by VEGF(121) infusion. Relaxation to acetylcholine was enhanced by the VEGF treatment (P<0.05). These data demonstrate that chronic infusion of VEGF(121) during late gestation restores glomerular filtration rate and endothelial function and reduces high blood pressure associated with placental ischemia. The present results suggest that VEGF(121) may be a candidate molecule for management of preeclampsia and its related complications. (Hypertension. 2010;55:380-385.)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Letter Obstetrics & Gynecology

Discovery of antiangiogenic factors in the pathogenesis of preeclampsia

S. Ananth Karumanchi, Towia Libermann

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2022)

Article Peripheral Vascular Disease

Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association

Vesna D. Garovic, Ralf Dechend, Thomas Easterling, Ananth Karumanchi, Suzanne McMurtry Baird, Laura A. Magee, Sarosh Rana, Jane V. Vermunt, Phyllis August, Vice Chair

Summary: Hypertensive disorders of pregnancy (HDP) are a major cause of morbidity and mortality for both mothers and fetuses worldwide. This report reviews the current literature on HDP, including epidemiology, pathophysiology, treatment guidelines, and associated complications.

HYPERTENSION (2022)

Article Public, Environmental & Occupational Health

Risk-Factor Based Lead Screening and Correlation with Blood Lead Levels in Pregnancy

Katherine M. Johnson, Aaron J. Specht, Jessica M. Hart, Saira Salahuddin, Adrienne L. Erlinger, Michele R. Hacker, Alan D. Woolf, Marissa Hauptman, S. Ananth Karumanchi, Karen O'Brien, Blair J. Wylie

Summary: Prenatal risk-factor based lead screening is underutilized and does not effectively distinguish between individuals with and without elevated blood levels. Further exploration is needed to assess the benefit and cost-effectiveness of universal lead testing.

MATERNAL AND CHILD HEALTH JOURNAL (2022)

Article Immunology

Complement blockade with eculizumab for treatment of severe Coronavirus Disease 2019 in pregnancy: A case series

Richard M. Burwick, Gabriela Dellapiana, Rachel A. Newman, Sarah D. Smithson, Mariam Naqvi, John Williams, Melissa S. Wong, Martha Bautista, Anna Gaden, Shamsah D. Kazani, Derek A. Dunn, Mark H. Ma, Sanjay Mitter, Jonathan P. R. Monteleone, Stephan R. Ortiz, Sara Ghandehari, Noah Merin, Mark Zakowski, S. Ananth Karumanchi

Summary: The study evaluated the use of eculizumab in pregnant and postpartum individuals with severe COVID-19. Results showed that all participants survived at Day 15 and remained alive and free of mechanical ventilation at Day 29. The treatment was found to be safe with no serious adverse events.

AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2022)

Article Obstetrics & Gynecology

Cardiovascular and hemodynamic consequences of recombinant placental growth factor administration in Guinea pigs

Adelene Y. Tan, Ken Kearney, Courtney Jenkins, S. Ananth Karumanchi, Walter Bee, Paul Kussie

Summary: Placental growth factor (PlGF) has acute vasodilatory effects on human resistance arteries and can decrease blood pressure when administered to male Guinea Pigs, leading to compensatory increase in heart rate.

HYPERTENSION IN PREGNANCY (2022)

Review Obstetrics & Gynecology

Clinical interpretation and implementation of the sFlt-1/PlGF ratio in the prediction, diagnosis and management of preeclampsia

Stefan Verlohren, Shaun P. Brennecke, Alberto Galindo, S. Ananth Karumanchi, Ljiljana B. Mirkovic, Dietmar Schlembach, Holger Stepan, Manu Vatish, Harald Zeisler, Sarosh Rana

Summary: Preeclampsia poses significant morbidity and mortality risks for both mother and baby. The discovery of circulating angiogenic factors in preeclampsia pathogenesis has advanced diagnosis and prognosis, but there is currently no consensus or clear guidance on their practical use in routine clinical practice.

PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH (2022)

Article Obstetrics & Gynecology

The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice*

Laura A. Magee, Mark A. Brown, David R. Hall, Sanjay Gupte, Annemarie Hennessy, S. Ananth Karumanchi, Louise C. Kenny, Fergus McCarthy, Jenny Myers, Liona C. Poon, Sarosh Rana, Shigeru Saito, Anne Cathrine Staff, Eleni Tsigas, Peter von Dadelszen

Summary: Uniform departmental management protocols should be maintained for managing hypertensive pregnant women, and regular audits of maternal and fetal outcomes should be conducted. The cause and optimal clinical management of pre-eclampsia and hypertensive disorders of pregnancy remain uncertain, therefore, it is recommended that every hypertensive pregnant woman be given the opportunity to participate in research, clinical trials, and follow-up studies.

PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH (2022)

Article Cardiac & Cardiovascular Systems

Animal Models of Cardiovascular Complications of Pregnancy

Zolt Arany, Denise Hilfiker-Kleiner, S. Ananth Karumanchi

Summary: Cardiovascular complications during pregnancy, such as preeclampsia and peripartum cardiomyopathy, have become a major cause of maternal mortality and have long-term effects on maternal cardiovascular health. However, the causes and mechanisms underlying these complications are not well understood, and treatment options are limited. Preclinical models have played an important role in advancing our understanding of these diseases.

CIRCULATION RESEARCH (2022)

Editorial Material Medical Laboratory Technology

Cell-Free RNA Transcriptome and Prediction of Adverse Pregnancy Outcomes

Kathryn J. Gray, Martin Hemberg, S. Ananth Karumanchi

CLINICAL CHEMISTRY (2022)

Article Medicine, Research & Experimental

Chemical optimization of siRNA for safe and efficient silencing of placental sFLT1

Sarah M. Davis, Vignesh N. Hariharan, Agnes Lo, Anton A. Turanov, Dimas Echeverria, Jacquelyn Sousa, Nicholas McHugh, Annabelle Biscans, Julia F. Alterman, S. Ananth Karumanchi, Melissa J. Moore, Anastasia Khvorova

Summary: Preeclampsia is a potentially lethal pregnancy complication driven by overexpression of placental soluble fms-like tyrosine kinase 1 (sFLT1). Researchers have found that injecting specific siRNA can reduce placental sFLT1 and improve symptoms. They also discovered that modifying siRNA chemically can enhance its effectiveness and safety, providing a framework for further development of this therapeutic approach.

MOLECULAR THERAPY-NUCLEIC ACIDS (2022)

Article Endocrinology & Metabolism

The Impact of Carbamylation and Anemia on HbA1c's Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease

Mengyao Tang, Anders Berg, Eugene P. Rhee, Andrew S. Allegretti, Sagar Nigwekar, S. Ananth Karumanchi, James P. Lash, Sahir Kalim

Summary: The impact of glycated hemoglobin (HbA(1c)) on renal outcomes in patients with diabetes and chronic kidney disease (CKD) is modified by carbamylation and anemia.

DIABETES CARE (2023)

Review Peripheral Vascular Disease

Fructose might be a clue to the origin of preeclampsia insights from nature and evolution

Takahiko Nakagawa, Ana Andres-Hernando, Tomoki G. Kosugi, Laura Sanchez-Lozada, Peter Stenvinkel, Karolina Kublickiene, S. Ananth Karumanchi, Duk-Hee Kang, Hideto Kojima, Bernardo R. Rodriguez-Iturbe, Dean A. Tolan, Miguel J. Lanaspa, Richard Johnson

Summary: Preeclampsia is a hypertensive disorder of pregnancy caused by abnormal placentation. Fructose, which plays a critical role in fetal growth, is produced in the placenta during early pregnancy to assist fetal survival in a hypoxic environment. Impaired placentation leads to excessive fructose production, which drives various pathological features of preeclampsia. In addition, dietary fructose intake has been identified as an independent risk factor for preeclampsia.

HYPERTENSION RESEARCH (2023)

Article Urology & Nephrology

Protein Carbamylation and the Risk of ESKD in Patients with CKD

Sahir Kalim, Sophia Zhao, Mengyao Tang, Eugene P. Rhee, Andrew S. Allegretti, Sagar Nigwekar, S. Ananth Karumanchi, James P. Lash, Anders H. Berg

Summary: Protein carbamylation, driven by elevated blood urea levels, is associated with adverse outcomes in ESKD. However, its relationship to clinical outcomes in earlier stages of CKD is not well understood.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)

Article Cardiac & Cardiovascular Systems

Smooth Muscle Mineralocorticoid Receptor Promotes Hypertension After Preeclampsia

Lauren A. Biwer, Qing Lu, Jaime Ibarrola, Alec Stepanian, Joshua J. Man, Brigett V. Carvajal, Nicholas D. Camarda, Zsuzsanna Zsengeller, Geraldine Skurnik, Ellen W. Seely, S. Ananth Karumanchi, Iris Z. Jaffe

Summary: Preeclampsia is associated with hypertension and end organ damage, and women exposed to preeclampsia have an increased risk of hypertension after pregnancy. This study found that exposure to sFlt1 during pregnancy leads to enhanced responsiveness of smooth muscle cell mineralocorticoid receptors (SMC-MR) to hypertensive stimuli, contributing to postpartum hypertension. These findings suggest that targeting SMC-MR could be a potential intervention to mitigate cardiovascular risk in women after preeclampsia.

CIRCULATION RESEARCH (2023)

Article Obstetrics & Gynecology

Perinatal mood and anxiety disorders: biomarker discovery using plasma proteomics

Eynav Accortt, James Mirocha, Dongsheng Zhang, Sarah J. Kilpatrick, Towia Libermann, S. Ananth Karumanchi

Summary: This study aimed to determine if a panel of novel third-trimester plasma protein biomarkers in pregnant women can be used to identify those who have a high predisposed risk for perinatal mood and anxiety disorders. The results showed that participants with perinatal mood and anxiety disorders had a unique and distinct plasma protein signature that regulated a variety of neuronal signaling and proinflammatory pathways. Further validation studies with larger sample sizes are needed to determine the potential use of these molecules for early detection of perinatal mood and anxiety disorders when combined with traditional risk factors.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2023)

暂无数据